Related Experiment Video

Updated: May 4, 2026

A New Murine Model of Endovascular Aortic Aneurysm Repair
08:51

A New Murine Model of Endovascular Aortic Aneurysm Repair

Published on: July 7, 2013

13.7K

Optimal lifelong roadmap post-acute coronary syndrome: a clinical consensus statement of the European Association of

Roberto F E Pedretti1,2, Emeline Van Craenenbroeck3, Christiaan Vrints3

  • 1School of Medicine and Surgery, University of Milano Bicocca, Via Cadore 48, 20900 Monza (MB), Italy.

European Journal of Preventive Cardiology
|April 22, 2026
PubMed

Insights

This consensus statement outlines a lifelong care roadmap for acute coronary syndrome (ACS) patients, improving long-term outcomes and equitable care across Europe. It addresses gaps in current guidelines for extended follow-up and integrated management strategies.

Area of Science:

  • Cardiology
  • Preventive Cardiology
  • Public Health

Background:

  • Acute coronary syndromes (ACS) are a significant cause of death and illness in Europe, with suboptimal long-term results.
  • Current guidelines lack comprehensive strategies for extended follow-up and integrated care post-ACS.
  • Healthcare systems show variability in post-ACS service implementation, leading to outcome disparities.

Purpose of the Study:

  • To establish an optimal, lifelong care roadmap for patients after an acute coronary syndrome (ACS).
  • To provide evidence-informed, equitable, and patient-centered management strategies adaptable to various healthcare settings.
  • To address the need for structured, phased care models for post-ACS recovery and prevention.

Main Methods:

  • A multidisciplinary expert group nominated by the European Association of Preventive Cardiology (EAPC) was convened.
  • A structured literature review and expert consensus process were employed.
  • Iterative discussions were held to define key components of post-ACS care across recovery phases.

Main Results:

  • A structured, phased model for lifelong patient care following ACS has been defined.
  • The roadmap integrates evidence, clinical expertise, and practical considerations for diverse healthcare settings.
  • It emphasizes continuity of care, professional collaboration, and technological integration for multiple patient phenotypes.

Conclusions:

  • The proposed roadmap offers a framework to optimize lifelong management for ACS survivors.
  • It aims to reduce mortality and morbidity by improving long-term outcomes and ensuring equitable access to care.
  • Implementation across European healthcare systems is supported to standardize and enhance post-ACS patient management.

Keywords:
Acute coronary syndromeCardiovascular riskMyocardial infarctionRoadmap

More Related Videos

ADSC-sheet Transplantation to Prevent Stricture after Extended Esophageal Endoscopic Submucosal Dissection05:57

ADSC-sheet Transplantation to Prevent Stricture after Extended Esophageal Endoscopic Submucosal Dissection

Published on: February 10, 2017

8.2K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.0K

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
943
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741